MyAverix Finance
US · Healthcare
Replimune Group Inc (REPL)
Biotechnology
Replimune Group Inc (REPL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for REPL
Replimune Group Inc (REPL) — FAQ
What is REPL's P/E ratio?
The price-to-earnings (P/E) ratio for Replimune Group Inc (REPL) is 18.00 (data as of 2026-03-24).
Does Replimune Group Inc pay a dividend?
Dividend yield is not available in the current snapshot for Replimune Group Inc (REPL). Check the MyAverix Finance app for the latest dividend data.
What sector is Replimune Group Inc in?
Replimune Group Inc (REPL) is classified in the Healthcare sector (Biotechnology industry).
What exchange is REPL listed on?
REPL is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.